CoChat

Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage

Open access
Reeder, A, Attar, M, Nazario, L, Bathula, C, Zhang, A, Hochbaum, D, Roy, E, Cooper, K L, Oesterreich, S, Davidson, N E, Neumann, C A, Flint, M S · 2015 · British Journal of Cancer
Cited by 93

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The mechanisms by which stress hormones impact triple-negative breast cancer (TNBC) etiology and treatment are unclear. We have previously shown that stress hormones, cortisol, and catecholamines induce rapid DNA damage and impact DNA repair in NIH 3T3 fibroblasts. This study investigates whether stress hormones increase DNA damage in breast cancer cells and if this impacts drug efficacy. METHODS: We first screened a panel of 39 breast cancer cell lines for expression of adrenergic and glucocorticoid receptors and examined if stress hormones induce DNA damage and alter cell cycle regulation in vitro. A TNBC xenograft model was used to assess the impact of restraint stress on tumour growth and chemosensitivity to paclitaxel. RESULTS: We found that stress hormones induced DNA damage, phosphorylation of ATR, which was accompanied by an up-regulation of the G1 cell kinase inhibitor p21 and a cell cycle halt of TNBCs in the G1 phase. p21 knockdown abrogated G1 arrest by stress hormones. We also demonstrated that stress significantly decreased efficacy of paclitaxel. CONCLUSION: We describe a novel mechanism through which stress hormones can induce drug resistance to paclitaxel, which may have profound implications for treating drug resistance in patients with TNBC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.2015.133

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 93

Metadata

Authors
Reeder, A., Attar, M., Nazario, L., Bathula, C., Zhang, A., Hochbaum, D., Roy, E., Cooper, K. L., Oesterreich, S., Davidson, N. E., Neumann, C. A., & Flint, M. S.
Venue
British Journal of Cancer
Published
2015-04
Volume
112
Issue
9
Pages
1461-1470
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2079351888
Cited by
93
References
12
FWCI
4.34
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage. https://app.cochat.ai/papers/10.1038/bjc.2015.133
The paper
Reeder, A., Attar, M., Nazario, L., Bathula, C., Zhang, A., Hochbaum, D., Roy, E., Cooper, K. L., Oesterreich, S., Davidson, N. E., Neumann, C. A., & Flint, M. S. (2015). Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage. British Journal of Cancer. https://doi.org/10.1038/bjc.2015.133

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.